IOF vs. SYNT, ZTF, TET, HAYD, WCH, DCTA, ITX, HDD, BIOM, and ESKN
Should you be buying Iofina stock or one of its competitors? The main competitors of Iofina include Synthomer (SYNT), Zotefoams (ZTF), Treatt (TET), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Directa Plus (DCTA), Itaconix (ITX), Hardide (HDD), Biome Technologies (BIOM), and Esken (ESKN). These companies are all part of the "specialty chemicals" industry.
Iofina vs. Its Competitors
Iofina (LON:IOF) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.
In the previous week, Synthomer had 1 more articles in the media than Iofina. MarketBeat recorded 1 mentions for Synthomer and 0 mentions for Iofina. Synthomer's average media sentiment score of 0.89 beat Iofina's score of 0.00 indicating that Synthomer is being referred to more favorably in the news media.
6.4% of Iofina shares are held by institutional investors. Comparatively, 43.8% of Synthomer shares are held by institutional investors. 45.1% of Iofina shares are held by insiders. Comparatively, 28.0% of Synthomer shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Iofina has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500. Comparatively, Synthomer has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500.
Iofina has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.
Iofina currently has a consensus price target of GBX 36.25, suggesting a potential upside of 48.57%. Synthomer has a consensus price target of GBX 212.50, suggesting a potential upside of 116.62%. Given Synthomer's higher probable upside, analysts plainly believe Synthomer is more favorable than Iofina.
Iofina has a net margin of 6.98% compared to Synthomer's net margin of -4.40%. Iofina's return on equity of 8.00% beat Synthomer's return on equity.
Summary
Iofina beats Synthomer on 10 of the 16 factors compared between the two stocks.
Get Iofina News Delivered to You Automatically
Sign up to receive the latest news and ratings for IOF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding IOF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:IOF) was last updated on 7/12/2025 by MarketBeat.com Staff
